NCT00000236
Completed
Phase 2
Buprenorphine Pharmacology Related to Addiction Treatment
ConditionsOpioid-Related Disorders
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Opioid-Related Disorders
- Sponsor
- National Institute on Drug Abuse (NIDA)
- Locations
- 1
- Primary Endpoint
- Drug use
- Status
- Completed
- Last Updated
- 20 years ago
Overview
Brief Summary
The purpose of this study is to examine the interactions between buprenorphine and naltrexone, and to assess how they may directly impact the clinical issues involving: transferring patients from buprenorphine to naltrexone, developing a non-abusable form of buprenorphine, and enhancing patient acceptability of naltrexone.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Drug use
Opioid agonist effects
Opiate withdrawal
Psychological changes in: pupil diameter, blood pressure, heart rate, respiration
Study Sites (1)
Loading locations...
Similar Trials
Completed
Phase 4
Naltrexone and Bupropion Combination on Obese,Smoking Patients With SchizophreniaObeseCigarette-smokingSchizophreniaNCT02736474Shanghai Mental Health Center22
Withdrawn
Phase 2
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment 1 - 1Heroin DependenceOpioid-Related DisordersNCT00000326University of Colorado, Denver
Withdrawn
Phase 2
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment III) - 3Heroin DependenceOpioid-Related DisordersNCT00000328University of Colorado, Denver
Completed
Phase 1
Effects of Buprenorphine and Naloxone in Opiate Addicts - 4Opioid-Related DisordersSubstance-Related DisordersNCT00000355National Institute on Drug Abuse (NIDA)
Recruiting
Phase 2
Efficacy of Buprenorphine and XR-Naltrexone Combination for Relapse Prevention in Opioid Use DisorderOpioid-use DisorderNCT05011266New York State Psychiatric Institute180